Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
1.230
-0.020 (-1.60%)
Apr 2, 2025, 4:00 PM EDT - Market closed
Apyx Medical Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Apyx Medical.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Apyx Medical stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
BTIG | BTIG | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 17, 2024 |
JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
Stephens & Co. | Stephens & Co. | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +306.50% | Nov 10, 2023 |
Piper Sandler | Piper Sandler | Buy Maintains $4 → $4.5 | Buy | Maintains | $4 → $4.5 | +265.85% | Aug 11, 2023 |
Stephens & Co. | Stephens & Co. | Buy Initiates $8 | Buy | Initiates | $8 | +550.41% | Jul 14, 2023 |
Financial Forecast
Revenue This Year
49.43M
from 48.10M
Increased by 2.76%
Revenue Next Year
53.06M
from 49.43M
Increased by 7.34%
EPS This Year
-0.39
from -0.66
EPS Next Year
-0.44
from -0.39
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 51.5M | 55.3M | 63.2M | ||
Avg | 49.4M | 53.1M | 61.4M | ||
Low | 46.7M | 50.5M | 59.0M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 7.2% | 11.9% | 19.1% | ||
Avg | 2.8% | 7.3% | 15.6% | ||
Low | -2.8% | 2.1% | 11.1% |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -0.40 | -0.45 |
Avg | -0.39 | -0.44 |
Low | -0.37 | -0.42 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.